Sugi Predict

Sugi Predict / Compounds / SCHEMBL3279467

SCHEMBL3279467

SCHEMBL3279467

Nc1ccccc1-c1ccccc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.68
▸ L3MBTL1 Q9Y468 1/20 0.68
▸ TSHR P16473 2/20 0.62
▸ DPP4 P27487 1/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ PLA2G7 Q13093 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ TP53 P04637 1/20 0.48
▸ NR4A2 P43354 1/20 0.46
▸ CYP3A4 P08684 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ CASP7 P55210 1/20 0.45
▸ HSD11B1 P28845 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17785867 1.00 ALDH1A1 (0.68) ALDH1A1L3MBTL1TSHRDPP4SMN1; SMN2
Hydrochloric Acid SCHEMBL28868989 0.97 ALDH1A1 (0.65) ALDH1A1L3MBTL1TSHRDPP4SMN1; SMN2
SCHEMBL21886424 0.85 ALDH1A1 (0.52) ALDH1A1L3MBTL1TSHRDPP4SMN1; SMN2
SCHEMBL20345882 0.83 ALDH1A1 (0.59) ALDH1A1L3MBTL1TSHRDPP4SMN1; SMN2
SCHEMBL397466 0.83 ALDH1A1 (0.59) ALDH1A1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL31607672 0.83 ALDH1A1 (1.00) ALDH1A1L3MBTL1TSHRSMN1; SMN2HSD17B10
SCHEMBL29802156 0.83 CYP2A6 (0.67) ALDH1A1TSHRDPP4SMN1; SMN2HSD17B10
SCHEMBL671133 0.83 CYP2A6 (0.67) ALDH1A1TSHRDPP4SMN1; SMN2HSD17B10
SCHEMBL29883244 0.83 CYP2A6 (0.67) ALDH1A1TSHRDPP4SMN1; SMN2HSD17B10
SCHEMBL169281 0.83 ALDH1A1 (1.00) ALDH1A1L3MBTL1TSHRSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122032423-A Catalyst for continuous production of 4' -chloro-2-aminobiphenyl, reaction system and process 厦门嘉氢科技有限公司 2026-05-15 — — CN claimed
CN-222623707-U 4-Chloro-2-aminobiphenyl extraction device 恒升德康(南京)医药科技有限公司 2025-03-18 — — CN claimed
CN-116640064-B Synthesis method of 4' -chloro-2-aminobiphenyl 山东京博农化科技股份有限公司 2025-03-04 — — CN claimed
CN-119080689-A Botrytis cinerea method for synthesizing amine 浙江新安化工集团股份有限公司 2024-12-06 — — CN claimed
CN-117903168-A Pyrrolo [2,3-d ] thiazole derivatives, and preparation method and application thereof 南开大学 2024-04-19 — — CN claimed
CN-113880759-B Preparation method of boscalid 江苏七洲绿色科技研究院有限公司 2023-09-05 — — CN claimed
CN-116640064-A Synthesis method of 4' -chloro-2-aminobiphenyl 山东京博农化科技股份有限公司 2023-08-25 — — CN claimed
CN-113831280-B Preparation method of boscalid 上海埃农生物科技有限公司 2023-08-15 — — CN claimed
CN-111039860-B Synthetic method and application of 2-hydroxy-N- (4' -chlorobiphenyl-2-yl) nicotinamide 河北科技大学 2022-09-13 — — CN claimed
CN-106366002-B A kind of Boscalid intermediate 4 '-chloro- 2- aminobphenyl synthetic method 京博农化科技股份有限公司 2019-01-22 — — CN claimed
CN-104725303-B The synthetic method of one kind 2 chlorine N (base of 4 ' chlordiphenyl 2) niacinamide 西安近代化学研究所 2017-09-08 — — CN claimed
CN-106719820-A A kind of agricultural bactericidal composition containing triazole bactericidal agent and preparation method thereof 东莞市联洲知识产权运营管理有限公司 2017-05-31 — — CN claimed
CN-106366002-A Synthesis method of intermediate 4'-chloro-2-aminobiphenyl of boscalid 京博农化科技股份有限公司 2017-02-01 — — CN claimed
CN-104478797-A Preparation method of nicotinamide fungicide namely boscalid SUZHOU TOKIND CHEMICAL CO LTD 2015-04-01 — — CN claimed
CN-102618061-B Preparation method for 2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrobenzophenone)azo]anilino]ethyl acetate SUZHOU LUOSEN AUX IES CO LTD 2013-08-07 — — CN claimed
CN-102618061-A Preparation method for 2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrobenzophenone)azo]anilino]ethyl acetate SUZHOU LUOSEN AUX IES CO LTD 2012-08-01 — — CN claimed
EP-1252140-B1 PYRROLECARBOXAMIDES AND PYRROLETHIOAMIDES AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2009-05-13 — — EP claimed
US-20090011935-A1 Method of Inducing Tolerance of Plants Against Bacterioses BASF SE (DE) 2009-01-08 — — US claimed
EP-1996018-A2 METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES BASF SE (DE) 2008-12-03 — — EP claimed
WO-2007104658-A2 METHOD OF INDUCING TOLERANCE OF PLANTS AGAINST BACTERIOSES BASF SE (DE) 2007-09-20 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090011935-A1 Method of Inducing Tolerance of Plants Against Bacterioses BROX, CAT, SLC11A2 ALDH1A1 2207/4885L3MBTL1 417/4885TSHR 3387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.